Cargando…
Malignant T cells activate endothelial cells via IL-17 F
Autores principales: | Lauenborg, B, Litvinov, I V, Zhou, Y, Willerslev-Olsen, A, Bonefeld, C M, Nastasi, C, Fredholm, S, Lindahl, L M, Sasseville, D, Geisler, C, Wasik, M M, Krejsgaard, T, Gjerdrum, L M R, Iversen, L, Odum, N, Woetmann, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549256/ https://www.ncbi.nlm.nih.gov/pubmed/28731459 http://dx.doi.org/10.1038/bcj.2017.64 |
Ejemplares similares
-
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
por: Sibbesen, Nina A., et al.
Publicado: (2015) -
Butyrate and propionate inhibit antigen-specific CD8(+) T cell activation by suppressing IL-12 production by antigen-presenting cells
por: Nastasi, Claudia, et al.
Publicado: (2017) -
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
por: Willerslev-Olsen, Andreas, et al.
Publicado: (2013) -
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
por: Willerslev-Olsen, Andreas, et al.
Publicado: (2020) -
B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)
por: Petersen, D L, et al.
Publicado: (2014)